Pancreatic cancer: molecular pathogenesis and emerging therapeutic strategies

By sjmartinez • January 4, 2026

Rozengurt E, Eibl G. Pancreatic cancer: molecular pathogenesis and emerging therapeutic strategies. Signal Transduct Target Ther. 2026 Jan 3;11(1):6. doi: 10.1038/s41392-025-02499-y. PMID: 41484057; PMCID: PMC12764932.

Tags: Digestive Diseases, Publications

Exploring Sex Differences in Irritable Bowel Syndrome Prevalence, Environmental Risk, and Comorbidities: A Population-Based Cohort Study of Veterans

Gasperi M, Gerstenberger A, Naliboff B, Afari N; VA Million Veteran Program. Exploring Sex Differences in Irritable Bowel Syndrome Prevalence, Environmental Risk, and Comorbidities: A[...]

Increased Autoimmunity Burden Is a Risk Factor for Developing Irritable Bowel Syndrome-Like Symptoms in Quiescent Inflammatory Bowel Disease

Chang A, Shahrvini B, Oh J, Prajapati DP, Baniqued M, Harmon R, Greb AC, Bonthala N, Sauk JS, Shin A, Chang L, Limketkai BN. Increased[...]

Strategies to build trustworthiness and increase diversity in colorectal cancer biospecimen research: a multi-phase, multi-site qualitative study

Roybal KL, Nava-Coulter B, Roberts J, Harden D, Castro S, Revette A, Connolly M, Johnson G, Rountree JA, Brodney S, Schoolcraft K, Drew DA, May[...]